Elsevier

Antiviral Research

Volume 92, Issue 3, December 2011, Pages 488-492
Antiviral Research

Short Communication
Rescue of HIV-1 long-time archived X4 strains to escape maraviroc

https://doi.org/10.1016/j.antiviral.2011.10.003Get rights and content

Abstract

Entry of Human Immunodeficiency Virus type 1 (HIV-1) into target cells is mediated by the CD4 receptor and a coreceptor, CCR5 or CXCR4. Maraviroc interferes with HIV entry by binding the CCR5 coreceptor. Virological failure to maraviroc-containing regimens can occur through the emergence of resistance, or through tropism evolution and broadened coreceptor usage. In the latter case, the physiological relevance of minority strains is a major concern.

Here we report a retrospective analysis of coreceptor-usage and evolution based on 454-ultra-deep-sequencing of plasma and Peripheral Blood Mononuclear Cell (PBMC)-derived envelope V3-loops, accounting for coreceptor usage, from a patient who failed a maraviroc-containing regimen through the emergence of X4 strains. The X4 maraviroc-escape variant resulted from recombination between a long time archived proviral sequence from 2003 (5′-portion, including the V3-loop) and the dominant R5 strains circulating in plasma at the time of maraviroc-treatment initiation (3′-portion). Phylogenetic analyses and BEAST modeling highlighted that an early diverse viral quasispecies underwent a severe bottleneck following reinitiation of HAART and repeated IL-2 cycles between 1999 and 2001, leading to the transient outgrowth and archiving of one highly homogeneous X4 population from plasma, and to the expansion in plasma of one PBMC-derived R5 strain. Under maraviroc selective pressure, the early, no longer detectable X4 strains archived in PBMC were partially rescued to provide X4-determinants to the main circulating strain.

Highlights

► Investigation of HIV-1 coreceptor usage in a patient failing maraviroc treatment. ► Coreceptor usage is assessed genotypically and phenotypically. ► Phylogenetic analysis is performed on V3-loop sequences. ► Recombination plays a key role in rescuing X4 strains that lead to maraviroc failure. ► Interleukin-2 has a strong impact on viral population diversity.

Section snippets

Ethical statement

This study was approved by the Luxembourg Comité National d’Ethique de Recherche and the patient provided informed consent to this study.

Conflicts of interest

All authors declare no conflict of interest.

Acknowledgments

The authors are extremely grateful to Alexander Thielen for fruitful and critical discussions on UDS sequence processing, and to Martin Daeumer for his advice and expertise in UDS generation.

Financial support: The study was supported by the Luxembourg Ministry of Research, Grant No. [MCESR 20081203]. FB was supported by a PhD fellowship form the Fonds National de Recherche, Luxembourg, Grant No. [TR-PHD BFR06-033].

References (20)

  • B. Shi et al.

    Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy

    Virology

    (2010)
  • J. Archer et al.

    Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing

    AIDS (London, England)

    (2009)
  • D.M. Asmuth et al.

    CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2

    Journal of acquired immune deficiency syndromes

    (2010)
  • F. Baatz et al.

    Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates

    PLoS ONE

    (2011)
  • Z.L. Brumme et al.

    Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals

    The Journal of infectious diseases

    (2005)
  • P. Dorr et al.

    Maraviroc (UK-427, 857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

    Antimicrob Agents Chemother

    (2005)
  • W. Fischer et al.

    Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing

    PLoS ONE

    (2010)
  • N. Funderburg et al.

    Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients

    PLoS One

    (2010)
  • S.S. Hwang et al.

    Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1

    Science

    (1991)
  • K.S. Lole et al.

    Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination

    Journal of virology

    (1999)
There are more references available in the full text version of this article.

Cited by (0)

View full text